Cyprodenate: Difference between revisions
Content deleted Content added
Updating {{drugbox}} (changes to verified fields - updated 'ChEMBL_Ref') per Chem/Drugbox validation (report errors or bugs) |
auto mw |
||
(27 intermediate revisions by 19 users not shown) | |||
Line 1: | Line 1: | ||
{{Short description|Chemical compound}} |
|||
{{drugbox |
|||
{{Drugbox |
|||
| Verifiedfields = changed |
|||
| |
| Watchedfields = changed |
||
⚫ | |||
⚫ | |||
⚫ | |||
| IUPAC_name = 2-dimethylaminoethyl 3-cyclohexylpropanoate |
| IUPAC_name = 2-dimethylaminoethyl 3-cyclohexylpropanoate |
||
| image=Cyprodenate.svg |
| image = Cyprodenate.svg |
||
| width= 200 |
| width = 200 |
||
<!--Clinical data--> |
|||
| tradename = |
|||
| Drugs.com = {{drugs.com|international|cyprodenate}} |
|||
⚫ | |||
<!--Identifiers--> |
|||
⚫ | |||
⚫ | |||
⚫ | |||
⚫ | |||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
|||
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
||
| ChemSpiderID = 64892 |
| ChemSpiderID = 64892 |
||
| ChEMBL = 2106590 |
|||
| InChI = 1/C13H25NO2/c1-14(2)10-11-16-13(15)9-8-12-6-4-3-5-7-12/h12H,3-11H2,1-2H3 |
|||
| UNII_Ref = {{fdacite|correct|FDA}} |
|||
⚫ | |||
⚫ | |||
| InChIKey = MPOYJPINNSIHAK-UHFFFAOYAN |
|||
| KEGG_Ref = {{keggcite|correct|kegg}} |
|||
⚫ | |||
<!--Chemical data--> |
|||
⚫ | |||
⚫ | |||
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChI = 1S/C13H25NO2/c1-14(2)10-11-16-13(15)9-8-12-6-4-3-5-7-12/h12H,3-11H2,1-2H3 |
| StdInChI = 1S/C13H25NO2/c1-14(2)10-11-16-13(15)9-8-12-6-4-3-5-7-12/h12H,3-11H2,1-2H3 |
||
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
||
| StdInChIKey = MPOYJPINNSIHAK-UHFFFAOYSA-N |
| StdInChIKey = MPOYJPINNSIHAK-UHFFFAOYSA-N |
||
⚫ | |||
⚫ | |||
| ATC_suffix= |
|||
⚫ | |||
| DrugBank= |
|||
⚫ | |||
⚫ | |||
⚫ | |||
| molecular_weight = 227.34 |
|||
| bioavailability= |
|||
| metabolism = |
|||
| elimination_half-life= |
|||
| excretion = |
|||
| pregnancy_category = |
|||
| legal_status = |
|||
⚫ | |||
}} |
}} |
||
'''Cyprodenate''' ('''Actebral''') is a [[stimulant]] drug.<ref>Dormard Y, Levron JC, Le Fur JM |
'''Cyprodenate''' ('''Actebral''') is a [[stimulant]] drug.<ref>{{cite journal | vauthors = Dormard Y, Levron JC, Le Fur JM | title = Pharmacokinetic study of maleate acid of 2-(N,N-dimethylaminoethanol-14C1)-cyclohexylpropionate (cyprodenate) and of N,N-dimethylaminoethanol-14C1 in animals | journal = Arzneimittel-Forschung | volume = 25 | issue = 2 | pages = 201–7 | date = February 1975 | pmid = 1173033 }}</ref> It was used for counteracting the effects of [[benzodiazepine]] tranquillizer drugs before the development of newer [[antidotes]] such as [[flumazenil]].<ref>{{cite journal | vauthors = Bobkov I, Morozov IS | title = [Correction of psychodepressive effects of benzodiazepine tranquilizers by administration of psychostimulants] | language = English | journal = Biulleten' Eksperimental'noi Biologii I Meditsiny | volume = 94 | issue = 10 | pages = 48–51 | date = October 1982 | pmid = 6129008 | doi = 10.1007/BF00827201 | s2cid = 19153614 }}</ref> It produces [[dimethylethanolamine]] as a [[metabolite]].{{citation needed|date=September 2018}} |
||
== See also == |
== See also == |
||
Line 41: | Line 42: | ||
== References == |
== References == |
||
{{Reflist}} |
{{Reflist}} |
||
{{Stimulants}} |
{{Stimulants}} |
||
{{Nootropics}} |
|||
{{Psychostimulants, agents used for ADHD and nootropics}} |
|||
⚫ | |||
{{Acetylcholine receptor modulators}} |
|||
{{Monoamine releasing agents}} |
|||
⚫ | |||
[[Category:Nootropics]] |
[[Category:Nootropics]] |
||
[[Category:Stimulants]] |
[[Category:Stimulants]] |
||
[[Category: |
[[Category:Propionate esters]] |
||
[[Category: |
[[Category:Dimethylamino compounds]] |
||
[[Category:Prodrugs]] |
[[Category:Prodrugs]] |
||
[[Category:Cyclohexyl compounds]] |
|||
Latest revision as of 07:57, 25 March 2024
Clinical data | |
---|---|
AHFS/Drugs.com | International Drug Names |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.036.025 |
Chemical and physical data | |
Formula | C13H25NO2 |
Molar mass | 227.348 g·mol−1 |
3D model (JSmol) | |
| |
| |
(verify) |
Cyprodenate (Actebral) is a stimulant drug.[1] It was used for counteracting the effects of benzodiazepine tranquillizer drugs before the development of newer antidotes such as flumazenil.[2] It produces dimethylethanolamine as a metabolite.[citation needed]
See also[edit]
References[edit]
- ^ Dormard Y, Levron JC, Le Fur JM (February 1975). "Pharmacokinetic study of maleate acid of 2-(N,N-dimethylaminoethanol-14C1)-cyclohexylpropionate (cyprodenate) and of N,N-dimethylaminoethanol-14C1 in animals". Arzneimittel-Forschung. 25 (2): 201–7. PMID 1173033.
- ^ Bobkov I, Morozov IS (October 1982). "[Correction of psychodepressive effects of benzodiazepine tranquilizers by administration of psychostimulants]". Biulleten' Eksperimental'noi Biologii I Meditsiny. 94 (10): 48–51. doi:10.1007/BF00827201. PMID 6129008. S2CID 19153614.